Astrocytes promote the formation and function of excitatory synapses in the CNS. However, whether and how astrocytes modulate inhibitory synaptogenesis are essentially unknown. We asked whether astrocytes regulate the formation of inhibitory synapses between hippocampal neurons during maturation in vitro. Neuronal coculture with astrocytes or treatment with astrocyte-conditioned medium (ACM) increased the number of inhibitory presynaptic terminals, the frequency of miniature IPSCs, and the number and synaptic localization of GABA A receptor (GABA A R) clusters during the first 10 d in vitro. We asked whether neurotrophins, which are potent modulators of inhibitory synaptic structure and function, mediate the effects of astrocytes on inhibitory synapses. ACM from BDNF-or tyrosine receptor kinase B (TrkB)-deficient astrocytes increased inhibitory presynaptic terminals and postsynaptic GABA A R clusters in wild-type neurons, suggesting that BDNF and TrkB expression in astrocytes is not required for these effects. In contrast, although the increase in the number of inhibitory presynaptic terminals persisted, no increase was observed in postsynaptic GABA A R clusters after ACM treatment of hippocampal neurons lacking BDNF or TrkB. These results suggest that neurons, not astrocytes, are the relevant source of BDNF and are the site of TrkB activation required for postsynaptic GABA A R modulation. These data also suggest that astrocytes may modulate postsynaptic development indirectly by stimulating Trk signaling between neurons. Together, these data show that astrocytes modulate inhibitory synapse formation via distinct presynaptic and postsynaptic mechanisms.
Introduction
Astrocytes play important roles in the development and function of neuronal circuitry. Astrocytes upregulate the formation of functional glutamatergic synapses in cultures of retinal ganglion cells, spinal motor neurons, and hippocampal neurons (Pfrieger and Barres, 1997; Ullian et al., 2001 Ullian et al., , 2004 Zhang et al., 2003; Hama et al., 2004; Christopherson et al., 2005) . Although astrocytes appear to signal to neurons by local contact as well as by the release of soluble factors, the cellular and molecular mechanisms by which astrocytes regulate synaptogenesis are not understood.
Several lines of evidence suggest that astrocytes modulate excitatory synapses presynaptically as well as postsynaptically. In purified retinal ganglion cell cultures, astrocyte-conditioned medium (ACM) dramatically increases the number of presynaptic contacts made between neurons, the quantal size and efficacy of neurotransmitter release, and the number of postsynaptic AMPA receptor clusters Ullian et al., 2001 Ullian et al., , 2004 . Astrocyte-derived cholesterol complexed to apolipoprotein E has been shown to be necessary and sufficient to induce functional presynaptic terminals Ullian et al., 2001 Ullian et al., , 2004 . In hippocampal neurons grown in vitro, integrinmediated contact between astrocytes and pyramidal neurons induces neuron-wide activation of PKC signaling that promotes the maturation of excitatory presynaptic terminals but has no effect on postsynaptic AMPA receptor clusters (Hama et al., 2004) . As synapses mature, astrocytes continue to modulate synaptic function by potentiating or suppressing activity at presynaptic glutamatergic terminals via the release of glutamate or ATP, respectively (Zhang et al., 2003; Fiacco and McCarthy, 2004) . These studies provide some insights into the signaling mechanisms by which astrocytes modulate glutamatergic presynaptic maturation and function.
Currently, the role of astrocytes in modulating inhibitory synapse formation and function is less well understood. Examination of current density in hippocampal cultures before synaptogenesis suggests that astrocytes contribute to the maintenance of GABA A receptors (GABA A Rs) in the neuronal membrane (Liu et al., 1996 (Liu et al., , 1997 . Embryonic hippocampal neurons grown on cortical astrocyte monolayers had larger GABA-induced Cl Ϫ currents relative to neurons grown only on poly-D-lysine in vitro (Liu et al., 1996) . Although the upregulation of GABA current density required Ca 2ϩ elevation in astrocytes, this effect was not dependent on direct contact with astrocytes, because ACM treatment mimicked the effects observed in cocultures (Liu et al., 1996 (Liu et al., , 1997 . Thus, soluble factors released by astrocytes modulate the distribution of GABA A receptors as synapses are formed. Astrocytes continue to provide soluble factors that regulate ongoing inhibitory synaptic transmission. In hippocampal slices, perisyn-aptic astrocytes release glutamate in response to GABA B receptor activation, which potentiates interneuron GABA release and inhibitory synaptic transmission onto pyramidal neurons (Kang et al., 1998) . These observations suggest that astrocytes modulate inhibitory synapse formation and function presynaptically and postsynaptically, prompting us to further examine the signaling mechanisms underlying these effects. Together, our data demonstrate that astrocytes modulate inhibitory synaptogenesis via distinct presynaptic and postsynaptic mechanisms and suggest that astrocytes enhance BDNF and tyrosine receptor kinase B (TrkB) signaling in neurons, thereby promoting the formation and postsynaptic localization of GABA A R clusters.
Materials and Methods
Cell cultures. Primary hippocampal neuronal cultures were prepared as described previously (Goslin et al., 1988) with minor modifications. Briefly, hippocampi were dissected from embryonic day 18 (E18) Sprague Dawley rats, dissociated for 20 min in Ca 2ϩ -and Mg 2ϩ -free HBSS containing 0.03% trypsin, triturated in DMEM (Invitrogen, Carlsbad, CA) supplemented with 10% heat-inactivated fetal bovine serum (FBS) and plated at 100,000 cells/ml in DMEM supplemented with 10% FBS, 10% Ham's F-12 (Invitrogen), and 1% penicillin and streptomycin (Invitrogen) on poly-L-lysine-coated coverslips in 12-well plates. For pure neuronal cultures, cytosine arabinoside (AraC) (10 M) was added to cultures 18 -20 h after plating to prevent glial proliferation. Culture media was changed to Neurobasal medium (Invitrogen) supplemented with B27 (Invitrogen) at 4 d in vitro (div). Cells were maintained at 37°C, 5% CO 2 , and 95% humidity in defined medium that was changed weekly.
The effects of acutely isolated and mature astrocytes (14 -21 div) were examined in neuron-astrocyte cocultures. For acute astrocyte cocultures, neurons were prepared in DMEM supplemented with 10% FBS, 10% Ham's F-12, and 1% penicillin and streptomycin as described above, without the addition of AraC, allowing astrocyte proliferation. At 4 div, when ϳ75-80% of cells were astrocytes (n ϭ 35 coverslips), culture media was changed to Neurobasal medium with B27, and cocultures were maintained for up to 21 div. For mature astrocyte cocultures, neurons were plated onto confluent monolayers of astrocytes grown on coverslips and maintained for up to 21 div in Neurobasal medium. No differences were observed in the effects of acutely isolated and mature astrocytes on GABA A R clustering [fold increase in GABA A R cluster number per 20 m dendrite compared with neuron-only controls, 2.35 Ϯ 0.57 (25) and 2.34 Ϯ 0.61 (25) in acute and mature cocultures at 4 div, respectively; p ϭ 0.40; Student's t test]. Thus, acutely isolated astrocyte cocultures were used for experiments unless otherwise specified.
Primary astrocyte cultures were prepared as described previously Zhang et al., 2003) . Briefly, hippocampi were dissected and rinsed in cold HEPES-buffered Earle's balanced salt solution (EBSS), dissociated in 0.125% trypsin for 20 min, and plated in T25 flasks in modified minimum essential medium (MMEM) supplemented with 10% heat-inactivated FBS, 2 mM L-glutamine, 14 mM sodium bicarbonate, 40 mM D-glucose, 1% sodium pyruvate, and 1% penicillin and streptomycin. Astrocytes were allowed to proliferate for 14 -21 d and, after reaching confluency, were rinsed in cold EBSS and shaken at 260 rpm for 18 -20 h in MMEM to remove neurons and other cell types. Purified astrocytes were then plated onto poly-D-lysine-coated coverslips at 400,000 cells/ml in MMEM. Culture medium was changed to Neurobasal medium, and coverslips were used for direct cocultures or ACM treatments within 1-3 d. Primary fibroblast cultures were prepared from meninges of E18 Sprague Dawley rats following a similar protocol. Coverslips were immunostained with an antibody against glial fibrillary acidic protein (GFAP) (1:500; rabbit polyclonal; Chemicon, Temecula, CA) to determine the purity of astrocytes in these cultures. Only coverslips with Ͼ90% purity were used for conditioned medium experiments.
For pure neuronal cultures treated with conditioned medium, neurons were plated in Neurobasal medium that had been conditioned by astrocytes or fibroblasts (14 -21 d of age) during the previous 24 -72 h. Sterile inserts with 3 m high-pore-density polyethylene terephthalate membranes (BD Biosciences, Franklin Lakes, NJ) were placed into each well, and coverslips with astrocyte or fibroblast monolayers were inverted 0.9 mm above neurons. Inserts remained in place throughout the culture duration.
Mice. To evaluate the role of BDNF and TrkB signaling, cultures were prepared from postnatal day 0 mice mutant for TrkB (Klein et al., 1993) (The Jackson Laboratory, Bar Harbor, ME) or BDNF (Ernfors et al., 1994 ) (The Jackson Laboratory) or from wild-type littermate controls. Mice were genotyped by PCR.
Growth factor or cholesterol treatments. Neurons were treated with 50 ng/ml BDNF or neurotrophin 3 (NT3) (Upstate Biotechnology, Lake Placid, NY) for 48 h at 8 -11 div. Neurotrophin scavenging was performed by the addition of 2 g/ml TrkB-IgG (binds BDNF and NT4/ NT5), TrkC-IgG (binds NT3), or control IgGs (a gift from Regeneron Pharmaceuticals, Tarrytown, NY) at 1 div until neurons were immunostained at 4, 7, or 10 div. In a subset of experiments, cultures were treated with IgG constructs for 24 -48 h at 8 -11 div. All treatments were replenished after 24 h.
To examine the effects of cholesterol on inhibitory synapse formation, pure neuronal cultures were treated with Neurobasal medium with B27 alone, medium plus 10 g/ml cholesterol , or ACM for 48 h starting at 8 div or for 7 d starting at 3 div. In these experiments, neurons were treated with ACM collected from purified confluent astrocyte cultures on the day of treatment, and astrocyte monolayer inserts were not included in the culture wells. All treatments were replenished after 48 h. Neuronal cultures were immunostained at 10 div.
Immunostaining and confocal microscopy. Neurons were fixed in 4% paraformaldehyde and 4% sucrose for 15 min, permeabilized with cold 0.25% Triton X-100 for 5 min, and blocked in 5% normal goat serum for 1 h at room temperature. Double and triple labeling were performed with combinations of primary antibodies: anti-GABA A R-␤2/␤3 (1:100; monoclonal; Chemicon), GAD-64 (1:10; monoclonal; Developmental Studies Hybridoma Bank, Iowa City, IA), GFAP (1:500; rabbit polyclonal; Chemicon), microtubule-associated protein 2 (MAP2) (1:1000; polyclonal; a gift from Dr. Virginia Lee, University of Pennsylvania School of Medicine), synaptophysin (SP) (1:500; monoclonal; Sigma, St. Louis, MO), synaptophysin (1:200; rabbit polyclonal; NeoMarkers, Fremont, CA), vesicular GABA transporter (VGAT) (1:1000; guinea pig polyclonal; Chemicon) or VGAT (1:200; mouse monoclonal; Synaptic Systems, Göttingen, Germany), and vesicular glutamate transporter 1 (VGLUT) (1:1000; guinea pig polyclonal; Chemicon). Antibodies were visualized after staining with the appropriate FITC-, rhodamine isothiocyanate-, or cyanine 5-conjugated secondary antibodies (all used at 1:200; Jackson ImmunoResearch, West Grove, PA). Cell viability was assessed at 10 div using a terminal deoxynucleotidyl transferasemediated biotinylated UTP nick end labeling (TUNEL) assay to label apoptotic nuclei (ApopTag fluorescein in situ apoptosis detection kit; Chemicon). Images were obtained using a laser-scanning confocal microscope (TCS 4D; Leica, Nussloch, Germany). In each image, laser light levels and detector gain and offset were adjusted so that no pixel values were saturated in regions analyzed.
Cell-surface biotinylation. Biotinylation assays were performed as described previously (Mammen et al., 1997; Jovanovic et al., 2004) . Briefly, cultures were incubated with 1 mg/ml sulfo-biotin-N-hydroxysuccinimide ester (Pierce, Rockford, IL) for 30 min at 4°C at 10 div and washed twice with PBS supplemented with 1 mg/ml bovine serum albumin to remove excess biotin. Cell lysates were collected, and biotinylated cell-surface proteins were precipitated using UltraLink Immobilized NeutrAvidin biotinbinding protein (Pierce) and resolved by SDS-PAGE.
Western blot analysis. Total cell and surface protein extracts were harvested into Laemli's buffer from pure neuronal and neuron-astrocyte cocultures at 10 div. After SDS-PAGE, samples were transferred to nitrocellulose membranes and probed for antibodies to GABA A R-␤3 (1:1000; rabbit polyclonal; a gift from Dr. S. J. Moss, University of Pennsylvania School of Medicine), neurofilament H (1:1000; monoclonal; Sternberger Monoclonals, Lutherville, MD), or K v 2.1 (1:1000; monoclonal; Chemicon) as loading controls for total and surface fractions, respectively. Alkaline phosphatase-conjugated goat anti-rabbit or anti-mouse antisera (1:5000; Applied Biosystems, Foster City, CA) were used, and signals were visualized using chemiluminescence (WesternStar detection sys-tem; Applied Biosystems). Films were digitally scanned, and signals were quantified using Universal Imaging (Downingtown, PA) MetaMorph software.
Electrophysiology. Whole-cell patch-clamp recording was performed at room temperature (20 -25°C) on pyramidal neurons at 9 -11 and 17-18 div using an Axopatch 200A amplifier and pClamp9 software (Axon Instruments, Union City, CA). Pyramidal neurons were distinguished from interneurons by cellular morphology, including a large pyramidalshaped soma and the presence of a prominent apical dendrite. Patch pipettes with a resistance of 2-3 M⍀ were filled with a solution containing the following (in mM): 140 KCl, 5 NaCl, 2 MgCl 2 , 1 CaCl 2 , 10 HEPES, 5 EGTA, 2 Mg-ATP, and 0.2 Li-GTP, pH 7.3, adjusted with KOH (319 mOsm). During recording, coverslips were continuously superfused with HEPES-buffered physiological salt solution composed of the following (in mM): 145 NaCl, 3 KCl, 1 MgCl 2 , 2 CaCl 2 , 10 dextrose, and 10 HEPES, pH 7.35, adjusted with NaOH (325 Osm). For recording spontaneous IPSCs, 50 M APV and 10 M CNQX were added to block NMDA and AMPA receptor-mediated currents, respectively. To record miniature IPSCs (mIPSCs), 1 M TTX was also added to block action potentials. Pipette voltage offset was neutralized before the formation of a gigaohm seal. Membrane resistance (R m ), series resistance (R s ), and membrane capacitance (C m ) were determined from current transients elicited by a 5 mV depolarizing step from a holding potential of Ϫ60 mV, using the "membrane test" application of pClamp9. Criteria for cell inclusion in the data set included a R s Յ 15 M⍀ and stability throughout the recording period, typically 2-3 min. Each recording was performed for a minimum of 2 min, IPSCs were amplified and then low-pass filtered at 2.5 kHz, and the sampling rate, performed using pClamp9, was 5 Hz.
The cumulative probability distributions of mIPSC interevent intervals were compared using the Kolmolgorov-Smirnov nonparametric test. Differences in mIPSC amplitude were compared using Student's t test.
Quantification and statistical analysis. For each condition, a minimum of 6 -10 randomly selected neurons were examined on each of three coverslips in three to six independent experiments. Pyramidal neurons were distinguished from interneurons by pyramidal morphology and lack of anti-GAD immunoreactivity. In all experiments, the number and colocalization of SPϩ and VGATϩ terminals and the number and synaptic localization of GABA A Rs were determined from confocal images using interactive software (MetaMorph; Universal Imaging). Images were thresholded, and the number of individual clusters along every dendrite of analyzed neurons was determined. Values are presented as mean Ϯ SEM (number of cells). Values for cluster number were compared using the Kruskal-Wallis nonparametric ANOVA test, followed by Dunn's pairwise multiple-comparison test.
Pixel overlap of SPϩ clusters with VGATϩ or VGLUTϩ clusters was used to distinguish between inhibitory and excitatory terminals, respectively. To quantify synaptic localization of GABA A Rs, receptor clusters with pixel overlap with SPϩ clusters were considered synaptic. For each parameter, the percentage of colocalization between cultures was compared using Student's t test.
Results

Astrocytes increase inhibitory presynaptic terminals and postsynaptic GABA A R clusters
To study the effects of astrocytes on inhibitory synapse formation, we first compared the development of presynaptic and postsynaptic specializations in low-density embryonic rat hippocampal neurons cultured in the presence and absence of astrocytes during the first 10 d in vitro. Immunostaining and confocal microscopy were performed at 4, 7, and 10 div using antibodies against SP to label presynaptic terminals, VGAT to distinguish inhibitory terminals, and the GABA A R-␤2/␤3 subunits to visualize postsynaptic receptors.
In the absence of astrocytes, the number of SPϩ boutons and GABA A R clusters gradually increased during the first week in vitro, consistent with previous reports (Table 1) (Brunig et al., 2001; Elmariah et al., 2004) . At 4 div, few SPϩ terminals were observed, and Ͻ2% of these inputs colocalized with VGATϩ clusters, suggesting that inhibitory terminals were rare (Table 1) . 
Values are shown as mean Ϯ SEM (number of cells from 3-6 separate experiments). In the three experiments at 4, 7, and 10 div, neurons were treated with ACM using a feeder layer of astrocytes on a membrane inverted in the culture well. In the fourth experiment at 10 div, ACM collected from purified astrocyte monolayers was added directly to neuronal cultures, and feeder layers were not used (for details, see Materials and Methods). In all experiments, cluster number was compared among conditions using Kruskal-Wallis ANOVA followed by Dunn's pairwise multiple-comparison test. The percentage of presynaptic and postsynaptic colocalization among cultures was compared using Student's t test. *p Ͻ 0.001, **p Ͻ 0.0001, and ***p Ͻ 0.05, significantly different from pure neuronal cultures. n.d., Not determined.
In a separate experiment, immunostaining with antibodies against SP, VGAT, and VGLUT to label glutamatergic terminals confirmed the presence of VGLUTϩ clusters at 4 div and demonstrated that ϳ80% of SPϩ terminals were excitatory (Table 1) . Consistent with the observation of few inhibitory presynaptic terminals, postsynaptic GABA A R immunoreactivity appeared diffuse throughout somata and proximal dendrites of pyramidal neurons with few clusters present ( Table 1 ). The number of presynaptic terminals steadily increased over time in culture to 4.8 SPϩ boutons per 20 m dendritic segment at 7 div and 6.8 boutons per 20 m at 10 div (Fig. 1 A; Table 1 ). VGLUTϩ clusters increased at a similar rate and continued to represent the majority of presynaptic terminals (Table 1) . Although VGAT expression increased in the soma and axons of interneurons during the first week, the number of inhibitory synaptic contacts represented only ϳ15% of synaptic contacts at 10 div (Fig. 1 A; Table  1 ). By 7-10 div, GABA A R clusters had begun to form, and ϳ10% of GABA A R clusters were apposed to presynaptic terminals (Fig. 1 A; Table 1 ). Thus, inhibitory synaptogenesis occurs slowly in the absence of astrocytes, with few inhibitory presynaptic terminals or postsynaptic GABA A R clusters present during the first 2 weeks in vitro.
When neurons were cultured in the presence of astrocytes, the rate of overall synaptogenesis and, in particular, inhibitory synapse formation, was dramatically increased at all ages. At 4 div, the total number of SPϩ presynaptic terminals increased by severalfold in the presence of astrocytes and appeared similar to levels observed in pure neuronal cultures at 10 div ( Table 1 ). The astrocyte-induced increase in presynaptic terminals was most robust at younger ages in vitro; however, levels remained at least twofold greater compared with controls at 7 and 10 div. Consistent with the increase in SPϩ terminals, more VGATϩ and VGLUTϩ clusters were observed in neuron-astrocyte cocultures compared with neuron-only cultures (Table 1) . VGATϩ clusters increased by Ͼ6.5-fold at 4 div, and by 7 and 10 div, inhibitory terminals were widely observed contacting somata and proximal dendrites of pyramidal neurons in astrocyte cocultures (Fig. 1 A; Table 1 ). In contrast, VGLUTϩ clusters increased by only approximately twofold in the presence of astrocytes, such that the proportion of inhibitory and excitatory SPϩ terminals appeared similar in astrocyte cocultures (Table 1). That is, in contrast to pure neuronal cultures, in which inhibitory synaptic contacts were rare, VGATϩ terminals consistently represented ϳ40 -50% of all SPϩ presynaptic contacts in neuron-astrocyte cocultures (Fig. 1 A) . Thus, astrocytes promote synaptogenesis by enhancing the formation of presynaptic terminals during maturation in vitro, robustly upregulating the number and proportion of inhibitory presynaptic contacts in developing hippocampal networks.
Astrocytes also increased the number of GABA A R clusters that had formed at 4, 7, and 10 div by over twofold relative to controls (Fig. 1 A; Table 1 ). Moreover, the proportion of GABA A R clusters apposed to presynaptic terminals was significantly increased, such that postsynaptic GABA A R clusters were present in cultures as early as 4 div, and Ͼ30% were synaptically localized at 7 and 10 div. As cultures matured, the effects of astrocytes on cluster number appeared less robust, because approximately the same number of GABA A R clusters had formed in pure neuronal and neuron-astrocyte cocultures by 3 weeks in vitro (Fig. 1 B) . In contrast, the proportion of GABA A R clusters localized to presynaptic sites Figure 1 . Astrocytes increase the number of inhibitory presynaptic terminals and postsynaptic GABA A R clusters in hippocampal neurons in vitro. Hippocampal neurons were cultured in the presence or absence of astrocytes and immunostained with antibodies against GABA A R-␤2/␤3 (green), SP (red), and VGAT (blue) to visualize inhibitory presynaptic terminals. A, The number of SPϩ and VGATϩ presynaptic terminals and the number of GABA A R clusters increased in neuron-astrocyte cocultures (right) compared with pure neuronal cultures (left) at 10 div. The proportion of GABA A R clusters apposed to presynaptic terminals also increased in neuron-astrocyte cocultures (Table 1) . Scale bar, 10 m. Areas within white boxes are shown in the panels below at a higher magnification. Scale bar (bottom right), 2 m. B, At 3 weeks in vitro, the proportion of GABA A R clusters localized to synapses (yellow) was approximately threefold greater in neuron-astrocyte cocultures (right) than in pure neuronal cultures (left). No differences were observed in the number of presynaptic terminals (red) or the number of GABA A R clusters (green). Scale bar, 10 m. Areas within white boxes are shown to the right at a higher magnification. Scale bar (bottom right), 2 m. remained greater in the presence than in the absence of astrocytes in older cultures (Fig. 1 B) . These observations suggest that astrocytes accelerate the rate of GABA A R cluster formation during early maturation in vitro and increase the number of inhibitory synapses, in part by increasing the localization of GABA A R clusters to synaptic sites.
We next asked whether the increase in inhibitory synapses resulted from a change in cell viability or interneuron density in the presence of astrocytes. Cell viability was assessed at 10 div using a TUNEL assay to label apoptotic nuclei. Few, if any, TUNELϩ nuclei were observed in either culture condition, and no differences were observed in the frequency of cell death in neuron-only and neuron-astrocyte cocultures [percentage of TUNELϩ nuclei per 16ϫ field (62,500 m 2 ), 0.2 Ϯ 0.2 (n ϭ 1682 cells) and 0.2 Ϯ 0.1 (n ϭ 1263 cells), p ϭ 0.7, Student's t test; in pure neuronal and neuron-astrocyte cocultures, respectively, not statistically different, Student's t test]. Moreover, analysis of cultures immunostained with antibodies against MAP2 to visualize neuronal processes, immunostained with GAD to distinguish inhibitory interneurons, and stained with 4Ј,6Ј-diamidino-2-phenylindole dihydrochloride to label nuclei revealed no differences in neuronal density or the proportion of interneurons in the presence or absence of astrocytes [number of neurons per 16ϫ field, 109.4 Ϯ 14.1 (n ϭ 10 fields) and 103.3 Ϯ 11 (n ϭ 10 fields) in pure neuronal cultures and neuron-astrocyte cocultures, respectively, p ϭ 0.7, Student's t test; percentage of interneuron population: 15.4 Ϯ 1.9 (n ϭ 17 fields) and 12.2 Ϯ 2.8 (n ϭ 18 fields) in pure neuronal cultures and neuron-astrocyte cocultures, respectively, p ϭ 0.3, Student's t test]. Finally, no significant differences were observed in the number or length of primary dendrites or in soma size of interneurons in the presence of astrocytes relative to controls [number of primary dendrites, 5.1 Ϯ 0.2 (n ϭ 65 cells) and 5.1 Ϯ 0.3 (n ϭ 62 cells); length of dendrites (in micrometers), 48.0 Ϯ 1.6 and 47.1 Ϯ 2.1; soma size (in square micrometers): 290.0 Ϯ 12.6 and 273.2 Ϯ 12.0 in pure neuronal and neuron-astrocyte cocultures, respectively; not statistically different; Student's t test). Similarly, pyramidal neuron morphology was unaffected in neuron astrocyte cocultures relative to controls [number of primary dendrites, 5. 9 Ϯ 0.4 (n ϭ 40 cells) and 5.6 Ϯ 0.5 (n ϭ 38 cells); length of dendrites (in micrometers), 44.3 Ϯ 4.9 and 41.7 Ϯ 5.1; soma size (in square micrometers), 347.9 Ϯ 26.4 and 387.5 Ϯ 26.2 in pure neuronal and neuron-astrocyte cocultures, respectively; not statistically different; Student's t test]. These results suggest that the increased number of inhibitory synapses observed in neuron-astrocyte cocultures is not attributable to an increase in the number or density of interneurons or the result of nonspecific trophic effects on cell health.
To determine whether glial modulation of inhibitory presynaptic terminals and/or GABA A R clusters required local contact or the release of soluble factors by astrocytes, pure neuronal cultures were treated with ACM during maturation in vitro. Neurons were plated onto coverslips in ACM, and astrocyte monolayers were plated onto separate coverslips that were inverted above neurons until immunostaining was performed at 4, 7, or 10 div. ACM treatment mimicked the effects of astrocyte coculture on both presynaptic terminal and GABA A R cluster number as well as their colocalization. In the presence of ACM, inhibitory presynaptic terminals increased by approximately fourfold, and the number of GABA A R clusters was increased by at least twofold throughout the first week in vitro, consistent with observations in cocultures (Fig. 2 A, B ; Table 1 ). Moreover, ACM treatment also increased the proportion of GABA A R clusters apposed to presynaptic terminals relative to untreated controls at all ages in vitro, to the same extent as in cocultures (Fig. 2 B; Table 1 ). In contrast, treatment with fibroblast-conditioned medium had no effect on presynaptic terminal or GABA A R cluster number and synaptic localization (Table 1) . These results show that the increase in presynaptic terminal and GABA A R cluster number, and their colocalization, were specific to ACM.
Previous work showed that cholesterol is a component of ACM that was sufficient to increase synaptic number and function . To test this possibility, cholesterol was added to purified neuronal cultures grown in Neurobasal medium. No increase in VGATϩ terminal number, GABA A R cluster number, or colocalization with inhibitory presynaptic terminals was observed after 48 h or 7 d of treatment with 10 g/ml cholesterol compared with untreated controls (Table 1) . Thus, the addition of cholesterol was not sufficient to mimic the effects of ACM on inhibitory synapses. Together, these results suggest that soluble factors other than cholesterol, released specifically from astrocytes, regulate the formation of inhibitory presynaptic terminals and postsynaptic GABA A R clusters in hippocampal pyramidal neurons.
Astrocytes increase GABA A R clusters expressed at the cell surface We next asked whether astrocyte modulation of GABA A R clustering and localization was accompanied by changes in total and/or cell-surface GABA A R expression. Protein lysates were collected from cells or after surface biotinylation and avidin precipitation in pure neuronal and neuron-astrocyte cocultures at 10 div, and Western blot analysis was performed.
No significant changes were observed in total GABA A R expression in neurons cultured in the presence or absence of astrocytes, suggesting that astrocytes modulate the distribution of GABA A receptors but do not alter receptor expression or degradation (Fig. 3A) . In contrast, levels of GABA A R protein expressed at the cell surface increased by over threefold in neuron-astrocyte cocultures relative to pure neuronal cultures (Fig. 3B) . These data suggest that, in the absence of astrocytes, GABA A R proteins are expressed, but the signals necessary for inducing cluster assembly are low or absent. Thus, astrocytes provide cues that promote the assembly of existing GABA A Rs into clusters and enhance the localization of GABA A Rs or GABA A R clusters in neuronal membranes.
Astrocytes increase the frequency of spontaneous inhibitory currents
To determine whether the astrocyte-induced increase in inhibitory terminals and postsynaptic GABA A R clusters resulted in an increase in the number of functional inhibitory connections, whole-cell patch-clamp recordings from pyramidal neurons were performed to examine IPSCs in the presence and absence of astrocytes.
Before the examination of inhibitory transmission, total neuronal activity was assessed at 10 div by recording all PSCs in the absence of glutamate receptor antagonists. In the absence of astrocytes, ϳ16% of neurons exhibited spontaneous PSCs at a low frequency (0.09 Ϯ 0.01 Hz; n ϭ 2 of 12 cells). In contrast, spontaneous PSCs were observed in Ͼ80% of pyramidal neurons in neuron-astrocyte cocultures and occurred with a mean frequency of 1.5 Ϯ 0.6 Hz (n ϭ 18 of 22 cells). In cocultures in which spontaneous activity was robust, IPSCs were pharmacologically isolated in the presence of APV and CNQX to block excitatory currents. Spontaneous IPSCs were observed at a mean frequency of 0.07 Ϯ 0.01 Hz (range, 0.02-0.1 Hz; n ϭ 10), and currents were 35.0 Ϯ 4.1 pA (n ϭ 17) in amplitude. The low level of spontaneous activity observed in pure neuronal cultures at 10 div before isolation of IPSCs precluded a direct quantitative comparison of the frequency and the amplitude of IPSCs between neurons cultured with or without astrocytes. Nonetheless, these data suggest that astrocytes increase the number of functional inhibitory connections by 10 div.
Whole-cell recordings were also performed at 17-18 div, when spontaneous inhibitory activity could be detected more reliably in pure neuronal cultures and mIPSCs could be isolated. The mean mIPSC frequency in neuron-astrocyte cocultures was twofold greater than in pure neuronal cultures (Fig. 4 A) [1.1 Ϯ 0.2 Hz (n ϭ 12) and 2.0 Ϯ 0.3 Hz (n ϭ 13) in pure neuronal cultures and neuron-astrocyte cocultures, respectively; p ϭ 0.03; Student's t test]. Because mIPSCs were not uniformly distributed throughout the recording period, interevent intervals were analyzed, and cumulative histograms of these intervals were compared (Fig. 4 B) . In the presence of astrocytes, the histogram of interevent intervals is shifted to the left, suggesting that the intervals between mIPSCs are shorter, consistent with an increase in the mean mIPSC frequency (Fig. 4 B) . In contrast, no difference was observed in the mean amplitude of mIPSCs in the presence or absence of astrocytes (Fig. 4C) [mean amplitude, 46 Ϯ 0.8 pA (n ϭ 12 cells; 1405 events) and 46 Ϯ 0.8 pA (n ϭ 13 cells; 2376 events); p ϭ 0.8; Student's t test]. These data demonstrate that Figure 2 . Astrocyte-conditioned medium increases the number of inhibitory synapses in hippocampal neurons in vitro. Hippocampal neurons were cultured in the presence of ACM, and inhibitory presynaptic terminals or GABA A R clusters were examined at 4, 7, and 10 div. A, Immunostaining was performed with antibodies against VGAT (green) and SP (red) to visualize inhibitory presynaptic terminals. The number of SPϩ boutons and the proportion of VGATϩ inhibitory terminals increased after ACM treatment (bottom) compared with untreated controls (top). Scale bar, 2 m. B, Immunostaining was performed with antibodies against GABA A R-␤2/␤3 (green) and SP (red). ACM treatment (bottom) resulted in an increase in the number and synaptic localization of GABA A R clusters (green) compared with pure neuronal cultures (top). Scale bar, 2 m. inhibitory transmission is elevated in neuron-astrocyte cocultures relative to controls, because of an increase in the number of inhibitory synapses and/or in the release probability of presynaptic nerve terminals. The astrocyte-induced increase in inhibitory synaptic activity is consistent with structural observations that astrocytes increase the number of inhibitory contacts.
Neurotrophins mediate astrocyte modulation of postsynaptic GABA A R clusters
These results suggest that diffusible factors exchanged between astrocytes and neurons promote the formation of functional inhibitory synapses. Neurotrophins, which can be released by and bind to Trk receptors expressed by neurons and glia, are known to play important roles in the development of inhibitory synapses presynaptically and postsynaptically, thus making them attractive candidates for mediating the effects of astrocytes on inhibitory synaptogenesis. In interneurons, BDNF enhances GAD mRNA and protein expression and facilitates presynaptic GABA release (Vicario-Abejon et al., 1998; Marty et al., 2000; Yamada et al., 2002) . In target pyramidal neurons, BDNF and TrkB signaling dynamically modulates the assembly, surface stability, and synaptic localization of GABA A R clusters (Brunig et al., 2001; Elmariah et al., 2004; Jovanovic et al., 2004) and increases postsynaptic GABA A receptor conductance (Rutherford et al., 1997) . These studies suggest that neurotrophin and Trk signaling may play a role in mediating the effects of astrocytes on the formation of presynaptic terminals and/or postsynaptic GABA A R clusters.
We tested this hypothesis by examining the effects of astrocytes or ACM on inhibitory terminals and GABA A R clusters when neurotrophin levels were reduced. Scavenging of endogenous BDNF and NT3 was achieved using Trk-IgG fusion proteins, which bind and sequester neurotrophins, preventing their binding to and activation of surface Trk receptors (Binder et al., 1999; Elmariah et al., 2004) . Hippocampal cultures were treated with 2.0 g/ml TrkB-IgG to scavenge BDNF, TrkC-IgG to scavenge NT3, or control IgG. Treatments began at 1 div and were replenished daily until immunostaining was performed at 4, 7, or 10 div.
Scavenging endogenous BDNF reduced the number of postsynaptic GABA A R clusters in pure neuronal cultures but had no effect on the number of inhibitory presynaptic terminals, consistent with our previous results (Elmariah et al., 2004) . In the presence of TrkB-IgG, fewer GABA A R clusters were observed at 4, 7, or 10 div in pure neuronal cultures (Fig. 5A-C) . Although no differences were observed in the number of presynaptic terminals between TrkB-IgG-treated and untreated cultures, BDNF scavenging reduced the proportion of GABA A R clusters localized to synapses by one-half during the first week in vitro (Fig. 5A-C) . Moreover, scavenging BDNF prevented the increase in postsynaptic GABA A R clusters observed in astrocyte-neuron cocultures or after ACM treatment. The decrease in synaptic GABA A R clusters primarily reflected postsynaptic changes, because the number of inhibitory presynaptic terminals remained elevated in cocultures relative to pure neuronal cultures, despite reduced BDNF levels (Fig. 5A-C) . Consistent with this hypothesis, TrkBIgG treatment led to an approximately sixfold reduction in the number of GABA A R clusters and an approximately eightfold decrease in their synaptic localization relative to untreated cocul- Figure 3 . Surface GABA A R expression is increased in hippocampal neurons in the presence of astrocytes. Total cell lysates or biotinylated surface protein extracts were harvested from hippocampal neurons cultured in the presence and absence of astrocytes at 10 div. A, Western blot analysis on total cell homogenates was performed using an antibody against the GABA A R-␤3 subunit (top) or neurofilament H (bottom) as a loading control. Quantification of relative band intensity compared with loading controls demonstrates no significant difference in the level of GABA A R-␤3 expression in the presence of astrocytes. B, Western blot analysis on surfacebiotinylated extracts was performed using an antibody against the GABA A R-␤3 subunit (top) or K v 2.1 (bottom) as a loading control. Quantification of relative band intensity compared with loading controls shows that GABA A R-␤3 expression at the neuronal surface is increased ϳ3.5-fold when neurons are cultured in the presence of astrocytes ( *p Ͻ 0.001). Error bars represent SEM. tures at 10 div (Fig. 5A-C) . Scavenging BDNF not only abolished the increase in postsynaptic GABA A R clusters induced by astrocytes but resulted in clustering similar to that observed in pure neuronal cultures after scavenging. These results suggest that astrocytes coordinately modulate the presynaptic and postsynaptic development of inhibitory synapses via Trk-dependent and -independent mechanisms and that BDNF signaling is required for neuronal as well as glial modulation of GABA A R clusters at inhibitory synapses.
We next asked whether TrkB signaling was necessary to maintain the increase in postsynaptic GABA A R clusters induced by astrocytes. Cultures were treated with 2.0 g/ml TrkB-IgG for 24 -48 h at 8 -10 div, after which astrocytes or ACM have already induced a robust increase in the number of postsynaptic GABA A R clusters (compare Figs. 1, 2 , and Table 1 ). Scavenging available BDNF levels in cultures containing astrocytes or treated with ACM even transiently resulted in significantly fewer GABA A R clusters and a decrease in the proportion GABA A R clusters localized to synapses ( Fig. 5D ; Table 2 ). Together, these findings indicate that BDNF signaling is necessary for and mediates, at least in part, astrocyte promotion of GABA A R cluster formation and synaptic maintenance.
We next asked whether the increase in GABA A R clustering and synaptic localization was specific to BDNF. In parallel experiments, the role of NT3 signaling in GABA A R cluster modulation in the presence and absence of astrocytes was examined. At early ages in vitro, scavenging endogenous NT3 with 2.0 g/ml TrkC-IgG had no effect on the number of GABA A R clusters observed in pure neuronal or neuron-astrocyte cocultures compared with untreated controls (data not shown). Similarly, no change was observed in the number or postsynaptic localization of GABA A R clusters when NT3 levels were reduced at 8 -10 div in pure neuronal cultures, consistent with previous results (Table 2) (Elmariah et al., 2004) . In the presence of astrocytes, however, scavenging NT3 for 48 h significantly increased the proportion of synaptically localized GABA A R clusters without changing the number of clusters observed at 10 div ( Fig.  5E ; Table 2 ). These observations indicate that, in contrast to BDNF signaling, NT3 signaling attenuates the localization of GABA A R clusters to synapses when neurons are cultured with astrocytes. This finding suggests that BDNF and NT3 signaling may be antagonistic with respect to inhibitory synapse formation.
We next examined the interactions of BDNF and NT3 signaling in modulating synaptic localization of GABA A R clusters in the presence of astrocytes. Neuron-astrocyte cocultures were treated with 50 ng/ml recombinant BDNF, NT3, or both, at 8 -10 div. Treatment with BDNF increased postsynaptic GABA A R clusters dramatically in pure neuronal cultures and, to a lesser degree, in neuron-astrocyte cocultures (Table 2 ). In contrast, NT3 treatment had no effect on postsynaptic GABA A R clusters in the absence of astrocytes and decreased the synaptic localization of GABA A R clusters in neuron-astrocyte cocultures (Table 2) . When neuron-astrocyte cocultures were treated with BDNF plus NT3, the number of GABA A R clusters appeared similar to BDNF-treated cultures, but fewer synaptically localized GABA A R clusters were observed (Table 2) . These results suggest that NT3 reduces the synaptic localization of GABA A R clusters in the presence of astrocytes. In contrast, cultures treated with TrkB-IgG and TrkC-IgG exhibited low levels of postsynaptic GABA A R clusters, similar to TrkB-IgG treatment alone, suggesting that BDNF must be present to increase GABA A R cluster formation and synaptic localization (Table 2 ). . Scavenging endogenous BDNF prevents the astrocyte-induced increase in the number and synaptic localization of GABA A R clusters. Hippocampal cultures with and without astrocytes were treated with 2.0 g/ml TrkB-IgG to scavenge endogenous BDNF or with TrkC-IgG to scavenge NT3 at different ages in vitro. Immunostaining was performed with antibodies against GABA A R-␤2/␤3 (green) and SP (red) at 4, 7, or 10 div. A, Treatment with 2.0 g/ml TrkB-IgG beginning at 1 div resulted in fewer postsynaptic GABA A R clusters in pure neuronal cultures (top) and neuron-astrocyte cocultures (bottom) at 4, 7, and 10 div. No change was observed in the number of SPϩ boutons after BDNF scavenging. Scale bar, 2 m. B, Quantification of TrkB-IgG effects on the number of GABA A R clusters per 20 m dendrite segment. *p Ͻ 0.001, significant difference compared with no treatment in pure neuronal cultures; **p Ͻ 0.001, significant decrease compared with no treatment in neuron astrocyte cocultures. C, Quantification of TrkB-IgG effects on the synaptic localization of GABA A R clusters. *p Ͻ 0.001, significant difference compared with no treatment in pure neuronal cultures; **p Ͻ 0.001, significant decrease compared with no treatment in neuron astrocyte cocultures. D, Treatment with 2.0 g/ml TrkB-IgG at 8 -10 div for 48 h decreased the number of postsynaptic GABA A R clusters in neuron-astrocyte cocultures (middle) (Table 2) compared with untreated controls (left). In contrast, treatment with 2.0 g/ml TrkC-IgG for 48 h increased the proportion of GABA A R clusters localized to synapses but had no effect on the number of GABA A R clusters (right) ( Table 2) . No change was observed in the number of SPϩ boutons after BDNF or NT3 scavenging. Scale bar, 2 m. Error bars represent SEM.
Together, these findings suggest that astrocytes dynamically modulate the number of postsynaptic GABA A R clusters, and thus inhibitory connections, via the regulation of neurotrophin and Trk signaling.
Astrocyte-mediated upregulation of GABA A R clusters requires neuronal BDNF release and TrkB activation
Previous work from our laboratory showed that BDNF and TrkB signaling in pure neuronal cultures are important for the formation and maintenance of GABA A R clusters (Elmariah et al., 2004) . Hippocampal pyramidal neurons produce and release BDNF, which binds and activates TrkB receptors on postsynaptic pyramidal neurons or interneurons (Ernfors et al., 1990; Du et al., 2000; Ivanova and Beyer, 2001; Kohara et al., 2001) . Astrocytes may modulate the magnitude or efficacy of this signaling between presynaptic and postsynaptic neurons, thereby enhancing inhibitory synapse formation. However, hippocampal astrocytes in vitro express BDNF mRNA and can release BDNF after stimulation (Condorelli et al., 1994; Alderson et al., 2000; Ivanova and Beyer, 2001; Miklic et al., 2004) . Thus, one alternative explanation for astrocyte effects on GABA A R clustering and synaptic localization is that astrocytes condition the culture medium with BDNF. To determine the relative importance of neurotrophin release from neurons and astrocytes on inhibitory synaptogenesis, neurons and astrocytes from postnatal mice deficient in BDNF and wild-type littermates were cultured in several combinations.
We first examined whether astrocyte-dependent modulation of GABA A R clusters required neuronal release of BDNF. Hippocampal neurons were cultured from postnatal BDNF-deficient mice or wild-type littermates in the presence or absence of wildtype ACM, and GABA A R clusters were examined after 10 div. In pure neuronal cultures from mutant mice, the formation and synaptic localization of GABA A R clusters was reduced in the absence of TrkB signaling relative to control wild-type cultures. Although the number of presynaptic terminals was similar, fewer postsynaptic GABA A R clusters were observed at 10 div in BDNFdeficient pyramidal neurons relative to wild-type neurons (Fig.  6 A-C) . In contrast to wild-type neurons, no changes were observed in GABA A R cluster number or synaptic localization at 10 div when BDNF-deficient neurons were cultured in the presence of wild-type ACM (Fig. 6 A-C) . These results suggest that astrocyte modulation of postsynaptic GABA A R clusters requires neuronal BDNF.
We next evaluated the role of astrocyte-derived BDNF in the modulation of inhibitory synapses. Embryonic rat hippocampal neurons were cultured for 10 div in the presence of ACM from astrocytes from BDNF-deficient or wild-type control mice, and GABA A R clusters were examined. After treatment with ACM from astrocytes from BDNF-deficient mice, the number of GABA A R clusters increased by ϳ2.5-fold, and synaptic localization increased by approximately fivefold compared with untreated controls (Fig. 6 D-F ) and appeared similar to cultures treated with wild-type ACM (Fig. 6 E, F ) . These results show that astrocyte production of BDNF is not required for modulation of postsynaptic GABA A R clusters. Together, our data suggest that astrocytes may modulate the neuronal release of BDNF via additional, as yet unknown, factors.
After its release, BDNF may bind to TrkB receptors expressed by hippocampal neurons or astrocytes. BDNF activation of fulllength TrkB receptor signaling in neurons plays numerous roles in neural development, including modulation of synapse formation and plasticity. Recent work has also shown that hippocampal astrocytes in vitro express high levels of truncated TrkB receptors and that BDNF activation of these receptors stimulates inositol-1,4,5-trisphosphate-dependent calcium release (Rose et al., 2003) . Thus, TrkB signaling in neurons and/or astrocytes may play a role in modulating inhibitory synaptogenesis in the cultures studied here. To determine whether glial modulation of GABA A R clusters requires the activation of TrkB signaling within neurons or astrocytes, cultures were prepared from postnatal mice lacking all isoforms of the TrkB receptor. First, to determine the importance of TrkB activation within neurons, GABA A R clusters were examined in hippocampal neurons cultured from TrkB-deficient or wild-type littermates in the presence or absence of wild-type ACM. Similar to BDNF-deficient neurons, TrkB-deficient neuronal cultures had fewer synaptic GABA A R clusters compared with control wild-type cultures. Moreover, in contrast to wild-type neurons, no changes were observed in GABA A R cluster number or synaptic localization when TrkB-deficient neurons were cultured in the presence of wildtype ACM (Fig. 7A-C) .
We next asked whether TrkB activation in astrocytes was also necessary for glial modulation of GABA A R cluster formation and synaptic localization. Hippocampal neurons were treated with ACM from TrkB-deficient or wild-type astrocytes, and GABA A R clusters were examined at 10 div. No differences were observed in the ability of ACM from TrkB-deficient or wild-type mouse astrocytes to increase GABA A R cluster formation and synaptic localization in wild-type neurons. Both TrkB-deficient and wildtype astrocytes induced an approximately fourfold increase in the number of GABA A R clusters and an approximately fivefold increase in the synaptic localization of these clusters (Fig. 7D-F ) . Thus, TrkB-mediated signaling in astrocytes is not required for glial modulation of inhibitory synaptogenesis. Together, these results demonstrate that neuronal release of BDNF is necessary, and furthermore, that neuronal TrkB activation is required for astrocyte modulation of GABA A R clusters. These data are consistent with our previous findings in pure neuronal cultures (Elmariah et al., 2004) and further suggest that astrocytes modulate neurotrophin signaling between neurons.
Discussion
We demonstrate that astrocytes promote the formation of presynaptic and postsynaptic specializations at inhibitory synapses in vitro demonstrating that BDNF is not required for the glial upregulation of inhibitory terminals. That BDNF cannot account for all of the synapse-promoting effects of ACM suggests that astrocytes coordinately regulate presynaptic and postsynaptic formation via distinct mechanisms. Determining the soluble factors released by astrocytes that modulate neurotrophin signaling in the developing hippocampus, and thereby postsynaptic neurotransmitter receptor clusters, will be a focus of future work.
Differential modulation of postsynaptic GABA A R clusters by opposing actions of BDNF and NT3 in the presence of astrocytes Currently, our understanding of the specific roles that astrocytes play in modulating the development of postsynaptic specializations is limited. In purified retinal ganglion cell cultures, increased AMPA-mediated EPSC amplitude was observed in the presence of ACM and reflects an increased number of AMPA receptor clusters at postsynaptic sites (Ullian et al., 2001) . Consistent with this work, Liu et al. (1996 Liu et al. ( , 1997 reported that astrocytes promote the maintenance of GABA A , glycine, and NMDA receptors expressed in dissociated hippocampal neurons after initial isolation from embryonic rats. Here, we provide evidence that astrocytes enhance the formation of GABA A R clusters during the first week in vitro and continue to promote the synaptic localization of these clusters as cultures mature.
Astrocytes regulate the stability of inhibitory synapses in hippocampal networks by dynamically regulating the assembly, delivery, and/or removal of postsynaptic GABA A R clusters. Our data support a role for astrocytes in promoting the stability of GABA A R clusters and the maintenance of inhibitory synapses via BDNF signaling. Scavenging BDNF in astrocyte cocultures or ACM-treated cultures after 1 week in vitro, when increased levels of postsynaptic GABA A R clusters are already apparent, results in a reduction of postsynaptic GABA A R clusters. Thus, in the absence of BDNF, GABA A R clusters are disassembled and/or removed from synaptic sites, consistent with previous observations in purified retinal ganglion cell cultures, in which the removal of ACM after 5 div led to the loss of glutamatergic synapses (Ullian et al., 2001) .
We also provide evidence that astrocytes can actively promote the disassembly of inhibitory synapses by inducing the removal GABA A R clusters from synaptic sites. When neurons are cultured with astrocytes, the addition of NT3 reduces the number of postsynaptic GABA A R clusters and attenuates the BDNFinduced increase in postsynaptic clusters. Moreover, scavenging endogenous NT3 at 8 -10 div resulted in an increase in GABA A R cluster localization to synapses. These results are consistent with previous findings that NT3 potentiates neuronal activity by downregulating GABAergic synaptic transmission in dissociated cortical neurons (Kim et al., 1994) . In addition, Paul et al. (2001) have shown that NT3 attenuates the BDNF-induced increase in EPSCs and IPSCs and c-fos expression in dissociated cultures of hippocampal neurons. NT3 is produced and released by embryonic hippocampal neurons as well as astrocytes (Rudge et al., 1992; Blondel et al., 2000; Wu et al., 2004) , but the relevant source of NT3 for modulating GABA A Rs in neuron-astrocyte cocultures remains to be determined. Manipulation of NT3 signaling in pure neuronal cultures has no effect on the synaptic localization of GABA A R clusters, suggesting that NT3 might be acting on astrocytes, provoking their release of other synaptic modulators, or that astrocytes modulate TrkC expression and responsivity to NT3 in neurons. Regardless, these results show that neurotrophins play an important role in mediating the effects by which astrocytes modulate postsynaptic GABA A R clusters and thus the formation of functional inhibitory synapses.
Glial modulation of neurotrophin signaling
Our work supports the idea that factors intrinsic to and exchanged between neurons, such as BDNF, are necessary for initial synapse formation and maintenance. In addition to providing extrinsic cues that directly modulate synapse formation and maturation, astrocytes may also alter the expression or activity of neuronal factors, such as neurotrophins and Trks, and thereby indirectly influence synaptic development. Consistent with this hypothesis, vasoactive intestinal polypeptide-stimulated astrocytes induce postsynaptic hippocampal neurons to release NT3, which acts presynaptically to promote the formation of glutamatergic synapses (Blondel et al., 2000) . Because neuronal-derived BDNF is required for glial effects on postsynaptic GABA A R clusters, astrocytes may similarly promote BDNF or TrkB expression by neurons, which in turn induces the formation of inhibitory synapses. The role of astrocytes in directly stimulating neurotrophin expression has not yet been evaluated. Astrocytes may also influence the availability of neurotrophins and their receptors by altering spontaneous neuronal activity, itself a potent stimulator of neurotrophin and Trk expression (Lindholm et al., 1994a,b; Tongiorgi et al., 1997) . How astrocytes release neurotrophins and/or modulate the expression and activity of BDNF/TrkB and NT3/TrkC in neurons remains to be explored. Finally, determining the mechanisms by which glia modulate Trk signaling will be essential for understanding how glia contribute to the establishment of mature neural networks.
